ASweetLife Team, Author at ASweetLife

FDA Approves Toujeo, Sanofi’s New Long Acting Insulin

The U.S. Food and Drug Administration (FDA) approved Sanofi’s new once daily long acting insulin, Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL) for treatment of adults living with type 1 and type 2 diabetes. Toujeo will be available in the Toujeo SoloSTAR, a disposable prefilled pen which contains 450 units of Toujeo and requires one third of the injection volume to deliver the same number of insulin units as compared to the Lantus SoloSTAR.

Diabetes Supply Cases Worth Carrying

Diabetes is rarely a glamorous condition, and that’s especially true when it comes to stashing and transporting all the high- and low-tech doodads we use to keep ourselves healthy. While most glucometers come with their own black vinyl zipper cases, you don’t have to be stuck with factory-issued fashion. Both men and women with diabetes have options than you may think.

JDRF and Janssen Team Up to Intercept Type 1 Diabetes

Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that it will invest in a novel scientific approach, called disease interception, to find ways to intercept type 1 diabetes using new diagnostic and pre-disease intervention strategies. If successful, this approach has the potential to transform the standard of care in type 1 diabetes.

21 Low Carb Valentine’s Dessert Recipes

Do you celebrate Valentine’s Day or do you write it off as the ultimate Hallmark holiday? Even if you choose to ignore Cupid and his cronies, the approach of February 14th is a great excuse to eat more chocolate. And it doesn’t have to be unhealthy, glucose-spiking indulgence either. You are sure to fall in love with these 21 great low carb Valentine dessert recipes.

British Researchers Discover Cell Behind Type 1 Diabetes

Knowing more about the type of T cell that causes type 1 is definitely good news for future treatments...

FDA Approves Glyxambi, New Type 2 Diabetes Medication

The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company’s Glyxambi for treatment of adults with type 2 diabetes. Glyxambi is the first and only diabetes treatment in the U.S. to combine the dual mechanisms of ....

Refresh Your Mental Carb Counting Tools

Whether you follow an unrestricted-carbohydrate, low-carbohydrate, or some-but-barely-any-carbohydrate diet, counting those carbohydrates is key to managing your blood sugar.

Medtronic Launches New Minimed 640G Insulin Pump (in Australia)

Medtronic, Inc. announced the global launch of the MiniMed 640G System, the next breakthrough toward an artificial pancreas. The system is the first in the world to both automatically suspend insulin delivery when sensor glucose levels are predicted to approach a low limit, and then resume insulin delivery once sensor glucose levels recover.

Where to Put Your Insulin Pump When There’s Nowhere to Put It

For all their algorithms, touchscreens, connectivity and convenience, most insulin pumps still have one thing working against them (and us): unless you have a pocket, there’s nowhere to put them. Here are a few tried and true – and maybe imperfect – ideas for keeping your pump on your person.

FDA Approves the t:flex, Tandem’s Larger Capacity Insulin Pump

The U.S. FDA has granted the Tandem Diabetes Care clearance to market the t:flex Insulin Pump. At 480 units, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the United States. The t:flex Pump is designed for people who require more than 100 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes...